Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount (Q35675498)

9 August 2017

title

Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount (English)

1 reference

9 August 2017

5

Otto C Boerman

1 reference

9 August 2017

6

Peter Laverman

1 reference

9 August 2017

Mark W Konijnenberg

1

1 reference

9 August 2017

Wout A P Breeman

2

1 reference

9 August 2017

Erik de Blois

3

1 reference

9 August 2017

Ho Sze Chan

4

1 reference

9 August 2017

Petra Kolenc-Peitl

7

1 reference

9 August 2017

Marleen Melis

8

1 reference

9 August 2017

Marion de Jong

9

1 reference

9 August 2017

publication date

30 August 2014

1 reference

9 August 2017

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

47

1 reference

Creative Commons Attribution 4.0 International

9 August 2017

copyright license

start time

30 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocr

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Dose-rate effects in external beam radiotherapy redux

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Use of normal tissue complication probability models in the clinic

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Dose-rate effects in targeted radiotherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy

12 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

The scaling method applied to beta particle line sources with a finite diameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4452684

Loss of Reirradiation Tolerance in the Kidney with Increasing Time after Single or Fractionated Partial Tolerance Doses

25 September 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13550-014-0047-1

Accuracy of the electron transport in mcnp5 and its suitability for ionization chamber response simulations: A comparison with the egsnrc and penelope codes

21 January 2018

1 reference

12 December 2020

Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats

1 reference

12 December 2020

Impact of tumor repopulation on radiotherapy planning

1 reference

12 December 2020

Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor

1 reference

12 December 2020

Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy

1 reference

12 December 2020

Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount

1 reference

12 December 2020

10.1186/S13550-014-0047-1

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference